5-amino-1mq and cd38 inhibitor combination benefits A systems-approach to NAD+ restoration Biological Functions and Therapeutic Potential

Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements

The optimal time for AOD-9604 administration is in a completely fasted state, typically first thing in the morning upon waking after an overnight fast of 8-10 hours

Subcutaneous injection was chosen as 5A-1MQ specifically has poor oral bioavailability in mice, a phenomenon that does not occur in rats 26

When a compound average effect is only 2 kilograms over 12 weeks, many individual participants likely saw minimal to no change, while a smaller subset may have responded more strongly, pulling the average up

Based on published evidence, semaglutide is the far more effective choice for fat loss, and AOD-9604 is now FDA-restricted (Category 2 bulk drug substance) for US compounding

Referenced Studies Only trained personnel should handle this compound